Follistim AQ Approval History beta

Follistim AQ (follitropin beta) is human follicle-stimulating hormone prescribed for women undergoing assisted reproductive treatments (ART) such as in vitro fertilization (IVF), and for the induction of ovulation to achieve pregnancy, and for men with hypogonadism.

FDA Approval History for Follistim AQ

DateArticle
Mar 24, 2004Approval Follistim AQ Organon USA Inc. - Treatment for Infertility

See also...

Follistim AQ (follitropin beta) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Advertisement
Close

Recommended

(web1)